Shiao-Pei Weathers

Shiao-Pei Weathers is an Associate Professor in the Department of Neuro-Oncology at The University of Texas MD Anderson Cancer Center. Her research focuses on glioblastoma and high-grade gliomas, specifically investigating novel therapeutic strategies, checkpoint inhibitor immunotherapy, and the molecular determinants of treatment response. She has led clinical trials evaluating agents such as regorafenib and peposertib in newly diagnosed and recurrent glioblastoma. Her recent work has identified distinct immune, mutation, and gut microbiome features associated with improved survival in anti-PD-L1 treated patients. She also examines patterns of care and outcomes for glioblastoma in young adult patients.